Home › Pulmonary Arterial Hypertension › Pennsylvania › Philadelphia
Pulmonary Arterial Hypertension clinical trials in Philadelphia, PA
6 studies for Pulmonary Arterial Hypertension are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- USA006, Philadelphia
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- Temple University, Philadelphia
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
RecruitingPhase 3
- The Hospital of the University of Pennsylvania, Philadelphia
- Temple Heart and Vascular Institute (Outpatient Clinic), Philadelphia
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
RecruitingPhase 2
- Children's Hospital of Philadelphia (CHOP) ( Site 1608), Philadelphia
Pulmonary Hypertension Association Registry
RecruitingObservational study
- University of Pennsylvania, Philadelphia
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
Pulmonary Arterial Hypertension trials in other cities
- Durham, NC7 studies
- Mountain View, CA7 studies
- Cincinnati, OH7 studies
- Kansas City, KS7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Nashville, TN7 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Los Angeles, CA4 studies
- Dallas, TX4 studies
- Houston, TX4 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.